Catalyst Funds Management Pty LTD Annexon, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $382 Billion
- Q1 2025
A detailed history of Catalyst Funds Management Pty LTD transactions in Annexon, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 11,760 shares of ANNX stock, worth $21,873. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,760Holding current value
$21,873% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding ANNX
# of Institutions
152Shares Held
96.7MCall Options Held
36.9KPut Options Held
83K-
Satter Management Co., L.P.7.41MShares$13.8 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$13 Million0.59% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$12.3 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$11.7 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.38MShares$10 Million0.0% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $88.6M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...